EXAMINING THE COST BENEFIT OF EARLY INTERVENTION FOR SEVERE AORTIC STENOSIS

AORTIC STENOSIS IS UNDERTREATED DESPITE KNOWN CLINICAL BENEFITS The ACC/AHA Guideline mandated treatment for severe aortic stenosis (SAS) is aortic valve replacement (AVR)[1].   While over 67,000 AVRs are performed in America each year for aortic stenosis, population statistics estimate that over 500,000 people in America have severe aortic stenosis [2-4], illustrating that aortic stenosis is […]